These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6989764)

  • 1. Humoral immune responses to human lymphoma cell heterotransplants in the central nervous system of athymic, nude mice.
    Adelman DC; Miller RA; Kaplan HS
    Int J Cancer; 1980 Apr; 25(4):467-73. PubMed ID: 6989764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology of the human malignant lymphomas. III. Intracranial heterotransplantation in the nude, athymic mouse.
    Epstein AL; Herman MM; Kim H; Dorfman RF; Kaplan HS
    Cancer; 1976 May; 37(5):2158-76. PubMed ID: 177185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral response against murine lymphoma cells xenogenized by drug treatment in vivo.
    Romani L; Puccetti P; Fioretti MC; Mage MG
    Int J Cancer; 1985 Aug; 36(2):225-31. PubMed ID: 3894248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous anti-tumor antibody responses in nude mice.
    Stigbrand T; Ullén A; Sandström P; Rathsman S; Rossi Norrlund R; Arlestig L; Riklund Ahlström K; Hietala SO
    Cancer; 1997 Dec; 80(12 Suppl):2404-10. PubMed ID: 9406690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor cells engineered with IL-12 and IL-15 genes induce protective antibody responses in nude mice.
    Orengo AM; Di Carlo E; Comes A; Fabbi M; Piazza T; Cilli M; Musiani P; Ferrini S
    J Immunol; 2003 Jul; 171(2):569-75. PubMed ID: 12847220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of mice against syngeneic lymphomata: I. Use of antibodies.
    Davies DA; Manstone AJ; Buckham S
    Br J Cancer; 1974 Oct; 30(4):297-304. PubMed ID: 4217193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth of diploid, Epstein-Barr virus-carrying human lymphoblastoid cell lines heterotransplanted into nude mice under immunologically privileged conditions.
    Giovanella B; Nilsson K; Zech L; Yim O; Klein G; Stehlin JS
    Int J Cancer; 1979 Jul; 24(1):103-13. PubMed ID: 225282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response to lymphoma antigens in syngeneic and H-2 compatible mice.
    Dalton JG; Fujimoto S; Sehon AH
    J Immunol; 1976 Nov; 117(5 Pt.2):1743-8. PubMed ID: 792331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumorigenicity of human malignant lymphoblasts: comparative study with unmanipulated nude mice, antilymphocyte serum-treated nude mice, and X-irradiated nude mice.
    Ohsugi Y; Gershwin ME; Owens RB; Nelson-Rees WA
    J Natl Cancer Inst; 1980 Oct; 65(4):715-8. PubMed ID: 6932523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumour antibodies in normal mouse sera.
    Martin SE; Martin WJ
    Int J Cancer; 1975 Apr; 15(4):658-64. PubMed ID: 1140865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective and cellular immune responses to idiotypic determinants on cells from a spontaneous lymphoma of NZB-NZW F1 mice.
    Sugai S; Palmer DW; Talal N; Witz IP
    J Exp Med; 1974 Dec; 140(6):1547-58. PubMed ID: 4139232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation of human malignant hematopoietic cells in immunodeficient mice: suppression by antibody to pluripotent K-562 leukemia cells involves direct cytolysis and effector cells.
    Lozzio BB; Machado EA; Mitchell J; Lozzio CB; Wust CJ; Golde DW
    Blood; 1983 Jun; 61(6):1045-53. PubMed ID: 6132631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 produced by pancreatic carcinoma cells enhances humoral immune responses against tumor cells: a possible event in tumor regression.
    Saito K; Ishikura H; Kishimoto T; Kawarada Y; Yano T; Takahashi T; Kato H; Yoshiki T
    Int J Cancer; 1998 Jan; 75(2):284-9. PubMed ID: 9462720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The humoral immune response of patients to their gliomas.
    Coakham HB; Kornblith PL
    Acta Neurochir Suppl (Wien); 1979; 28(2):475-9. PubMed ID: 290238
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo and in vitro properties of malignant variants of RAW117 metastatic murine lymphoma/lymphosarcoma.
    Reading CL; Kraemer PM; Miner KM; Nicolson GL
    Clin Exp Metastasis; 1983; 1(2):135-51. PubMed ID: 6549599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental chemotherapy of heterotransplanted Hodgkin- and non-Hodgkin-lymphoma cell lines in nude mice.
    Kirchner HH; Engert A; Diehl V
    Behring Inst Mitt; 1984 May; (74):329-36. PubMed ID: 6477360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatoid factor positive plasma and humoral cytotoxicity to malignant melanoma.
    Twomey JJ; Rossen RD; Lewis VM; Morgan AC; McCormick KJ
    Cancer; 1978 Apr; 41(4):1307-12. PubMed ID: 305818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies produced by in vitro immunization with sera of human-xenotransplant-bearing mice.
    Sproll MW; Spindler E; Anderer FA
    Immunol Lett; 1988 Jan; 17(1):29-33. PubMed ID: 3280477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor radioimmunolocalization in a murine system using monoclonal antibodies.
    Mènard S; Miotti S; Tagliabue E; Parmi L; Buraggi GL; Colnaghi MI
    Tumori; 1983 Jun; 69(3):185-90. PubMed ID: 6408776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison patterns of 4 T1 antigens recognized by humoral immune response mediated by IgG and IgM antibodies in female and male mice with breast cancer using 2D-immnunoblots.
    Díaz-Zaragoza M; Hernández-Ávila R; Govezensky T; Mendoza L; Meneses-Ruíz DM; Ostoa-Saloma P
    Immunobiology; 2015 Sep; 220(9):1050-8. PubMed ID: 26026196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.